H Hirasawa

582 total citations
35 papers, 449 citations indexed

About

H Hirasawa is a scholar working on Epidemiology, Surgery and Nephrology. According to data from OpenAlex, H Hirasawa has authored 35 papers receiving a total of 449 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 9 papers in Surgery and 7 papers in Nephrology. Recurrent topics in H Hirasawa's work include Sepsis Diagnosis and Treatment (6 papers), Metabolism and Genetic Disorders (4 papers) and Renal function and acid-base balance (4 papers). H Hirasawa is often cited by papers focused on Sepsis Diagnosis and Treatment (6 papers), Metabolism and Genetic Disorders (4 papers) and Renal function and acid-base balance (4 papers). H Hirasawa collaborates with scholars based in Japan and United States. H Hirasawa's co-authors include H Shiga, Kenji Matsuda, Kazushige Nakanishi, Baue Ae, Seitaro Oda, Chaudry Ih, Masataka Nakamura, Kenichi Matsuda, Yoshiro Kobe and Michio Odaka and has published in prestigious journals such as Journal of Clinical Investigation, Annals of Surgery and Critical Care.

In The Last Decade

H Hirasawa

33 papers receiving 432 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H Hirasawa Japan 11 189 114 99 78 57 35 449
H. Dittmer Germany 8 185 1.0× 92 0.8× 179 1.8× 90 1.2× 116 2.0× 31 569
G. Marécaux Belgium 5 218 1.2× 165 1.4× 145 1.5× 60 0.8× 63 1.1× 7 502
Hinshaw Lb United States 14 197 1.0× 111 1.0× 112 1.1× 68 0.9× 125 2.2× 33 555
L. T. Archer United States 15 246 1.3× 139 1.2× 102 1.0× 68 0.9× 120 2.1× 36 627
Weil Mh United States 11 148 0.8× 65 0.6× 164 1.7× 79 1.0× 53 0.9× 42 424
Ilias Andrianakis Greece 12 144 0.8× 49 0.4× 73 0.7× 70 0.9× 86 1.5× 21 398
J Gómez-Jiménez Spain 7 157 0.8× 83 0.7× 66 0.7× 23 0.3× 37 0.6× 11 393
Olga Livaditi Greece 12 196 1.0× 111 1.0× 44 0.4× 87 1.1× 83 1.5× 21 422
Simona B. Neff Switzerland 8 95 0.5× 144 1.3× 61 0.6× 53 0.7× 91 1.6× 8 380
Alan Sori United States 5 133 0.7× 108 0.9× 160 1.6× 86 1.1× 103 1.8× 11 487

Countries citing papers authored by H Hirasawa

Since Specialization
Citations

This map shows the geographic impact of H Hirasawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Hirasawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Hirasawa more than expected).

Fields of papers citing papers by H Hirasawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H Hirasawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Hirasawa. The network helps show where H Hirasawa may publish in the future.

Co-authorship network of co-authors of H Hirasawa

This figure shows the co-authorship network connecting the top 25 collaborators of H Hirasawa. A scholar is included among the top collaborators of H Hirasawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H Hirasawa. H Hirasawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hirasawa, H, Taichi Sugai, & Kiyoshi Matsuda. (2010). Acute Blood Purification. Contributions to nephrology. 87(7). 1317–22. 4 indexed citations
2.
Kobe, Yoshiro, Seitaro Oda, Kenichi Matsuda, Masataka Nakamura, & H Hirasawa. (2007). Direct Hemoperfusion with a Cytokine-Adsorbing Device for the Treatment of Persistent or Severe Hypercytokinemia: A Pilot Study. Blood Purification. 25(5-6). 446–453. 27 indexed citations
3.
Hirasawa, H, et al.. (2004). Sequential measurement of IL-6 blood levels in patients with systemic inflammatory response syndrome (SIRS)/sepsis. Cytokine. 29(4). 169–175. 194 indexed citations
4.
Hirasawa, H, Taichi Sugai, Seitaro Oda, Hidetoshi Shiga, & Tomohito Sadahiro. (1999). CLINICAL BENEFITS OF CYTOKINE REMOVAL WITH CONTINUOUS HEMODIAFILTRATION (CHDF) IN CRITICAL CARE. Shock. 12(Supplement). 51–51. 1 indexed citations
5.
Kodama, Masashi, Tomoko Tani, H Hirasawa, et al.. (1997). Treatment of sepsis by plasma endotoxin removal: hemoperfusion using a polymyxin-B immobilized column. Journal of Endotoxin Research. 4(4). 293–300. 43 indexed citations
6.
Hirasawa, H, Takeshi Sugai, Seitaro Oda, et al.. (1996). [Prevention and treatment of postoperative septic MOF and DIC and efficacy of blood purification].. PubMed. 97(12). 1079–84. 2 indexed citations
7.
Hirasawa, H, et al.. (1995). Indication and Efficacy of Blood Purification in the Treatment of Multiple Organ Failure : Symposium 4A : Identifications and Effects of Apheresis on Multiple Organ Failure and Fulminant Hepatitis. 14(1). 38–40. 1 indexed citations
8.
Ogawa, Miho, et al.. (1994). A fatal case of acute renal failure associated with non-fulminant hepatitis A.. PubMed. 42(3). 205–6. 4 indexed citations
9.
Hirasawa, H, et al.. (1989). [Perioperative water and electrolyte metabolism and its abnormalities in aged patients].. PubMed. 26(3). 240–5. 1 indexed citations
10.
Inaba, Hideo, H Hirasawa, & Toru Mizuguchi. (1988). Serum Osmolality Gap in Postoperative Patients in Intensive Care. Survey of Anesthesiology. 32(2). 114–114. 3 indexed citations
11.
Inaba, Hideo, et al.. (1987). Effects of salbutamol and hyperventilation on the rise in serum potassium after succinylcholine administration. Acta Anaesthesiologica Scandinavica. 31(6). 524–528. 1 indexed citations
12.
Hirasawa, H, et al.. (1983). Improved survival and reticuloendothelial function with intravenous ATP-MgCl2 following hemorrhagic shock.. PubMed. 11(2). 141–8. 12 indexed citations
13.
Hirasawa, H, Mitsuharu Kodaka, & Hirokazu Sato. (1983). [Management of acute ischemic renal failure with ATP-MgCl2].. PubMed. 25(7). 812–5. 2 indexed citations
14.
Ih, Chaudry, H Hirasawa, & Baue Ae. (1979). Impairment of reticuloendothelial system function with sepsis and its improvement with ATP-MgCl2 plus glucose administration.. PubMed. 2. 153–62. 11 indexed citations
16.
Hirasawa, H, et al.. (1978). Improved hepatic function and survival with adenosine triphosphate-magnesium chloride after hepatic ischemia.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 83(6). 655–62. 50 indexed citations
17.
Hirasawa, H, Chaudry Ih, & Baue Ae. (1978). Beneficial effect of ATP-MgCl2-glucose administration on survival following sepsis.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 29. 11–4. 7 indexed citations
18.
Rapaport, Franck, R Bachvaroff, Kôji Watanabe, et al.. (1978). Induction of Allogeneic Unresponsiveness in Adult Dogs. Journal of Clinical Investigation. 61(3). 790–800. 10 indexed citations
19.
Ft, Rapaport, et al.. (1977). Cellular factors. Immunologic tolerance: irradiation and bone marrow transplantation in induction of canine allogeneic unresponsiveness.. Transplantation Proceedings. 9(1). 891–4. 10 indexed citations
20.
Ft, Rapaport, et al.. (1976). Genetic studies of bone marrow transplantation in the canine species.. PubMed. 8(3). 423–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026